CIRM Board Member Calls Proposition 14 'Fatally Flawed' and 'Unaffordable"
The San Diego Union-Tribune this morning carried an op-ed piece by a long-time director of the California stem cell agency that said this fall's $5.5 billion ballot stem cell ballot measure is "unaffordable, unnecessary and fatally flawed."
The article was written by Jeff Sheehy, an HIV/AIDS patient advocate member of the agency's board and who was also…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.